Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Silence Therapeutics Price : 4.00 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Oct 01, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 50.00 |
| Sep 30, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 29, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 28, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 25, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 24, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 23, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 100.00 |
| Sep 22, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 21, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 18, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 17, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 16, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 15, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 14, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 11, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 10, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 09, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 08, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 04, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 03, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 02, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Sep 01, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Aug 31, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
| Aug 28, 2026 | 4.00 | 4.00 | 4.00 | 4.00 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 0.6199 |
| NuCana Plc | 1.09 |
| Mereo BioPharma Group Plc | 0.3798 |
| Compass Pathways Plc | 11.90 |
| HemoGenyx Pharmaceuticals Plc | 2.33 |
Price Related Metrics
| PS Ratio | 921.65 |
| Price to Book Value | 14.74 |
| Earnings Yield | -10.58% |
| Market Cap | 566.96M |